| | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2021 | H79SP080131 | Healthy Chelsea Coalition | 01 | 5 | CDC | 10/12/2021 | 073130411 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $610,949,887 ) (Continued on the next page) |
| | 2021 | 2021 | R4032753 | Maternal and Child Health Field-Initiated Research Program | 00 | 3 | HRSA | 4/30/2021 | 073130411 | $300,000 |
| | 2021 | 2021 | H79SP080131 | Healthy Chelsea Coalition | 00 | 5 | CDC | 6/18/2021 | 073130411 | $125,000 |
| | 2021 | 2021 | T6242054 | Integrated Substance Use Disorder (SUD) Training Program | 00 | 1 | HRSA | 6/2/2021 | 073130411 | $81,877 |
| | 2021 | 2021 | T6242054 | Integrated Substance Use Disorder (SUD) Training Program | 00 | 1 | HRSA | 6/2/2021 | 073130411 | $2,485,948 |
| | 2021 | 2021 | T2537602 | Addiction Medicine Fellowship | 00 | 2 | HRSA | 5/26/2021 | 073130411 | $799,838 |
| | 2021 | 2021 | OT2HL161841 | Interactive Data Portals and Robust Analytic Tools to Wrap PASC Cohorts (iDRAW) OTA-21-015A | 000 | 1 | NIH | 6/10/2021 | 073130411 | $8,634,924 |
| | 2021 | 2021 | OT2HL161841 | Interactive Data Portals and Robust Analytic Tools to Wrap PASC Cohorts (iDRAW) OTA-21-015A | 001 | 1 | NIH | 6/28/2021 | 073130411 | $26,407 |
| | 2021 | 2021 | OT2HL161841 | Interactive Data Portals and Robust Analytic Tools to Wrap PASC Cohorts (iDRAW) OTA-21-015A | 002 | 1 | NIH | 8/20/2021 | 073130411 | $8,661,331 |
| | 2021 | 2021 | OT2HL161841 | Interactive Data Portals and Robust Analytic Tools to Wrap PASC Cohorts (iDRAW) OTA-21-015A | 002 | 1 | NIH | 8/20/2021 | 073130411 | $40,612,263 |
| | 2021 | 2021 | OT2HL161841 | Interactive Data Portals and Robust Analytic Tools to Wrap PASC Cohorts (iDRAW) OTA-21-015A | 002 | 1 | NIH | 8/20/2021 | 073130411 | -$8,661,331 |
| | 2021 | 2021 | R56AI156711 | The Celiac Disease Genome, Environment, Microbiome, and Metabolome (CD-GEMM) prospective cohort study | 000 | 6 | NIH | 9/3/2021 | 073130411 | $410,315 |
| | 2021 | 2021 | HITEP180042 | MA/Region 1 Partnership for Regional Health Disaster Response | 12 | 1 | DHHS/OS | 9/23/2021 | 073130411 | $1,500,000 |
| | 2021 | 2021 | R33NS116423 | Development and Validation of a Clinically Relevant Animal Pain Model | 000 | 2 | NIH | 8/26/2021 | 073130411 | $388,584 |
| | 2021 | 2021 | R01DA051540 | Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain | 000 | 1 | NIH | 9/21/2021 | 073130411 | $785,235 |
| | 2021 | 2021 | R01HD105266 | The Genomic Architecture of Pregnancy Loss | 000 | 1 | NIH | 9/22/2021 | 073130411 | $577,034 |
| | 2021 | 2021 | K01TW012180 | Brief Transdiagnostic Treatment for Anxiety Disorders and PTSD in South Africa: A Hybrid-Effectiveness Trial | 000 | 1 | NIH | 9/20/2021 | 073130411 | $182,860 |
| | 2021 | 2021 | RF1AG074008 | Impact of sex differences in immune function on shared risk for cardiometabolic disorder & Alzheimer's disease | 000 | 1 | NIH | 9/20/2021 | 073130411 | $3,788,451 |
| | 2021 | 2021 | R01EB032746 | CRCNS: Computational Modeling of Microvascular Effects in Cortical Laminar fMRI | 000 | 1 | NIH | 9/6/2021 | 073130411 | $174,042 |
| | 2021 | 2021 | R01FD007287 | Effect of Oral Cimetidine in the Protoporphyrias (IND 153247 submitted 9/2/2020) | 000 | 1 | FDA | 9/10/2021 | 073130411 | $498,495 |
| | 2021 | 2021 | R21AR079718 | Limited-duration anabolic therapy in postmenopausal osteoporosis | 000 | 1 | NIH | 9/17/2021 | 073130411 | $214,400 |
| | 2021 | 2021 | R01AG064947 | Characteristics and impact of chronic pain and pain management in older adults | 000 | 1 | NIH | 9/21/2021 | 073130411 | $334,931 |
| | 2021 | 2021 | UH3AR076741 | Imaging Epigenetic Dysregulation in Patients with Low Back Pain | 000 | 2 | NIH | 8/30/2021 | 073130411 | $1,899,288 |
| | 2021 | 2021 | U01AI163086 | Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab | 000 | 1 | NIH | 9/14/2021 | 073130411 | $2,710,272 |
| | 2021 | 2021 | R01AG073410 | Comparative Safety of Seizure Prophylaxis within the Medicare Program | 000 | 1 | NIH | 9/24/2021 | 073130411 | $841,695 |
| | 2021 | 2021 | R01HD102975 | NeuroDev Kenya: characterizing the epidemiology and etiology of developmental disorders on the Kenyan Coast | 000 | 1 | NIH | 9/21/2021 | 073130411 | $30,000 |
| | 2021 | 2021 | R01HD102975 | NeuroDev Kenya: characterizing the epidemiology and etiology of developmental disorders on the Kenyan Coast | 000 | 1 | NIH | 9/21/2021 | 073130411 | $576,048 |
| | 2021 | 2021 | R56NS123271 | Deciphering the role of Microglia in Glioblastoma | 000 | 1 | NIH | 9/24/2021 | 073130411 | $554,102 |
| | 2021 | 2021 | R35GM142553 | Probing structural and biophysical mechanisms of mitochondrial membrane ultrastructure | 000 | 1 | NIH | 9/8/2021 | 073130411 | $409,800 |
| | 2021 | 2021 | P01CA261669 | Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy. | 000 | 1 | NIH | 9/21/2021 | 073130411 | $2,940,354 |
| | 2021 | 2021 | U01CA260758 | Proteomic Analyses of Serial Prediagnostic PLCO Serum in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls | 000 | 1 | NIH | 9/15/2021 | 073130411 | $546,231 |
| | 2021 | 2021 | R21MH127231 | Leveraging Computer Vision to Augment Suicide Risk Prediction | 000 | 1 | NIH | 8/26/2021 | 073130411 | $265,545 |
| | 2021 | 2021 | R21DK130004 | Noninvasive Nephritis Imaging | 000 | 1 | NIH | 9/17/2021 | 073130411 | $208,827 |
| | 2021 | 2021 | U01HL160278 | Mass General Brigham HeartShare Clinical Center | 000 | 1 | NIH | 9/7/2021 | 073130411 | $285,309 |
| | 2021 | 2021 | UH3TR002878 | Molecular dissection and imaging of extracellular vesicles to define their origin and targets | 000 | 3 | NIH | 9/15/2021 | 073130411 | $1,100,083 |
| | 2021 | 2021 | R03EB032038 | A Simulation Framework for X-Ray Phase-Contrast Imaging | 000 | 1 | NIH | 8/31/2021 | 073130411 | $179,294 |
| | 2021 | 2021 | DP5OD031854 | Revealing tissue microstructure in the brain gray matter in Alzheimer's disease using in vivo high-gradient diffusion MRI | 000 | 1 | NIH | 9/14/2021 | 073130411 | $1 |
| | 2021 | 2021 | DP5OD031854 | Revealing tissue microstructure in the brain gray matter in Alzheimer's disease using in vivo high-gradient diffusion MRI | 000 | 1 | NIH | 9/14/2021 | 073130411 | $419,999 |
| | 2021 | 2021 | R03AG074059 | Frailty in Inflammatory Bowel Diseases | 001 | 1 | NIH | 8/31/2021 | 073130411 | $0 |
| | 2021 | 2021 | R03AG074059 | Frailty in Inflammatory Bowel Diseases | 000 | 1 | NIH | 8/10/2021 | 073130411 | $168,000 |
| | 2021 | 2021 | K08AR079615 | Defining the antigenic determinants of the adaptive immune response in IgG4-related disease | 000 | 1 | NIH | 8/9/2021 | 073130411 | $174,960 |
| | 2021 | 2021 | R21DK127227 | Differential impact of smoking on the transcriptome and epigenome in Crohn's disease and ulcerative colitis" | 000 | 2 | NIH | 8/20/2021 | 073130411 | $167,500 |
| | 2021 | 2021 | R21EB031982 | Multiplexed device for rapid coagulopathy testing | 000 | 1 | NIH | 9/9/2021 | 073130411 | $462,000 |
| | 2021 | 2021 | R01HL159514 | Characterization of Functional Iron Deficiency and Repletion in Heart Failure with Preserved Ejection Fraction | 000 | 1 | NIH | 8/12/2021 | 073130411 | $643,638 |
| | 2021 | 2021 | UM1HG012010 | Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing | 000 | 1 | NIH | 8/23/2021 | 073130411 | $1,033,149 |
| | 2021 | 2021 | UM1HG012010 | Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing | 001 | 1 | NIH | 9/24/2021 | 073130411 | $0 |
| | 2021 | 2021 | R34DA053686 | Stigma-Treatment Enhanced Incentivized Directly Observed Therapy for People with HIV who Inject Drugs | 000 | 1 | NIH | 8/20/2021 | 073130411 | $228,383 |
| | 2021 | 2021 | R01DK127171 | Determinants of inception of inflammation in inflammatory bowel diseases | 000 | 1 | NIH | 8/24/2021 | 073130411 | $1,129,731 |
|
